Since there are case reports of immunosuppressed patients(but also immunocompetent individuals) developing COVID-19reinfection, also psoriatic patients who already had COVID-19infection should be considered for the vaccination.Registries enrolling dermatological patients undergoingSARS-CoV-2 vaccination and proactive pharmacovigilance activities especially focusing on patients under immunosuppressants are urgently needed to guide clinical practice.
Insights into {COVID}-19 vaccination in patients with chronic plaque psoriasis on~systemic treatments
P Gisondi
Writing – Original Draft Preparation
;
2021-01-01
Abstract
Since there are case reports of immunosuppressed patients(but also immunocompetent individuals) developing COVID-19reinfection, also psoriatic patients who already had COVID-19infection should be considered for the vaccination.Registries enrolling dermatological patients undergoingSARS-CoV-2 vaccination and proactive pharmacovigilance activities especially focusing on patients under immunosuppressants are urgently needed to guide clinical practice.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Acad Dermatol Venereol - 2021 - Gisondi - Insights into Sars‐CoV‐2 vaccination in patients with chronic plaque psoriasis on.pdf
accesso aperto
Licenza:
Dominio pubblico
Dimensione
120.59 kB
Formato
Adobe PDF
|
120.59 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
